Recently, CHAF1A has been associated with the development and progression of solid tumors, including breast cancer, prostate squamous cell carcinoma, hepatocellular carcinoma (HCC), glioma and neuroblastoma [39–43]. This evidence concerns the gene CHAF1A and breast carcinoma.